HCPLive Network

In Young People, Sudden Cardiac Death can be Caused by Gene Defects

Researchers from Germany’s Institute for Forensic Medicine have discovered that ion channel disorders like long QT syndromes, catecholaminergic polymorphic ventricular tachycardia, and the Brugada syndrome may account for one-third of unexplainable sudden cardiac death (SCD) in young people.

The researchers subcategorized cardiac gene defects into two groups: disorders that are accompanied by structural cardiovascular abnormalities, such as arrhythmogenic right ventricular dysplasia and hypertrophic cardiomyopathy; and disorders that do not have cardiac changes detectable at the time of death with a cause that is mostly arrhythmogenic, like the ion channels responsible for one-third of the SCD cases in young people.

The team of researchers found that post-mortem genetic screening for the presence of sequence variations in cardiac ion channel genes was helpful in ascertaining the cause of SCD in otherwise unclear cases.

SCD is listed as one of the most common causes of death in Europe, and although it usually happens among older people, 5-10% of cases there occur in young and apparently healthy people. The study adds that as many as 7,000 asymptomatic children in the US die from SCD each year, almost half of whom never show earlier symptoms.

In their findings, the researchers discussed that the majority of the ion-channel diseases are hereditary with an autosomal-dominant transmission, meaning that half of the children of individuals affected by SCD will be impacted as well.

In the event that sequence variations are identified, family members of the deceased should then undergo further medical tests. The researchers hope that these new findings will allow for individual risk analysis among impacted family members, who can then be provided with prophylactic treatment, such as an implantable cardioverter defibrillator.

For more information, click here.


Further Reading
Good news, bad news. Bad news: Sometimes a port-of-call has to be suffered because the value lies beyond. Good news: Sometimes the shore excursion brings you to a destination so delightful you’d like the day never to end as happens in Uniworld’s excursion to Bergerac on its Bordeaux cruise.
Interim study results presented at ACG 2014 indicate that treatment with vedolizumab safely and effectively maintains long-term clinical remission and response in patients with Crohn’s disease and ulcerative colitis.
A child receives the wrong medication or the wrong dosage every 8 minutes in the United States, according to a study published online Oct. 20 in Pediatrics.
A three-minute diagnostic assessment (3D-Confusion Assessment Method) has high sensitivity and specificity for identifying delirium, according to a study published in the Oct. 21 issue of the Annals of Internal Medicine.
In the era of rapidly improving cure rates for hepatitis C infection, has the importance of staging as part of treatment diminished?
Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.
New research provides some of the first concrete support for a treatment guideline that has long been recommended on grounds of common sense alone: Patients who suffer severe allergic reactions such as anaphylaxis should follow up on their emergency room care by seeing an allergist or immunologist.
More Reading